Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 362

1.

Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.

Cejas NG, Villamil FG, Lendoire JC, Tagliafichi V, Lopez A, Krogh DH, Soratti CA, Bisigniano L.

Liver Transpl. 2013 Jul;19(7):711-20. doi: 10.1002/lt.23665.

2.

Impact of MELD score implementation on liver allocation: experience at a Brazilian center.

da Silva Machado AG, de Medeiros Fleck A Jr, Marroni C, Zanotelli ML, Cantisani G, de Mello Brandão AB.

Ann Hepatol. 2013 May-Jun;12(3):440-7.

3.

A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.

Vitale A, Volk ML, De Feo TM, Burra P, Frigo AC, Ramirez Morales R, De Carlis L, Belli L, Colledan M, Fagiuoli S, Rossi G, Andorno E, Baccarani U, Regalia E, Vivarelli M, Donataccio M, Cillo U; Liver Transplantation North Italy Transplant program (NITp) working group.

J Hepatol. 2014 Feb;60(2):290-7. doi: 10.1016/j.jhep.2013.10.010. Epub 2013 Oct 23. Erratum in: J Hepatol. 2014 Jun;60(6):1336. Multiple investigator names added.

PMID:
24161408
4.

Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.

Salvalaggio PR, Afonso RC, Pereira LA, Ferraz-Neto BH.

Transplant Proc. 2012 Oct;44(8):2283-5. doi: 10.1016/j.transproceed.2012.07.045.

PMID:
23026574
5.

The MELD system and liver transplant waiting-list mortality in developing countries: lessons learned from São Paulo, Brazil.

Salvalaggio P, Afonso RC, Pereira LA, Ferraz-Neto BH.

Einstein (Sao Paulo). 2012 Jul-Sep;10(3):278-85. English, Portuguese.

6.

Model for end-stage liver disease-sodium and survival benefit in liver transplantation.

Vitale A, Bertacco A, Gambato M, D'Amico F, Morales RR, Frigo AC, Zanus G, Burra P, Angeli P, Cillo U.

Transpl Int. 2013 Feb;26(2):138-44. doi: 10.1111/tri.12008. Epub 2012 Nov 29.

7.

Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.

Schlansky B, Chen Y, Scott DL, Austin D, Naugler WE.

Liver Transpl. 2014 Sep;20(9):1045-56. doi: 10.1002/lt.23917. Epub 2014 Aug 4.

8.

Results after the adoption of a MELD/PELD-based liver allocation policy in Argentina.

Dip M, Cejas N, Cervio G, Villamil F, Tagliafichi V, Hansen Krogh D, Imventarza O, Soratti C, Bisigniano L.

Pediatr Transplant. 2015 Feb;19(1):56-61. doi: 10.1111/petr.12395. Epub 2014 Nov 21.

PMID:
25414131
9.

The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis.

Dutkowski P, Oberkofler CE, Béchir M, Müllhaupt B, Geier A, Raptis DA, Clavien PA.

Liver Transpl. 2011 Jun;17(6):674-84. doi: 10.1002/lt.22228.

10.

Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.

Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N.

Transplant Proc. 2012 Mar;44(2):389-92. doi: 10.1016/j.transproceed.2012.01.037.

PMID:
22410024
11.

Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.

Tenório AL, Macedo FI, Miranda LE, Fernandes JL, da Silva CM, Neto OL, Lacerda CM.

Transplant Proc. 2010 Mar;42(2):407-11. doi: 10.1016/j.transproceed.2010.01.005.

PMID:
20304152
12.

Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil.

Pestana RC, Baracat EI, Massarollo PC, Pereira LA, Szutan LA.

Transplant Proc. 2013 Jul-Aug;45(6):2111-4. doi: 10.1016/j.transproceed.2012.11.007. Epub 2013 Jun 5.

PMID:
23747144
13.

Liver transplantation for hepatocellular carcinoma: the MELD impact.

Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, Byrne T, Vargas HE, Mulligan D, Rakela J, Wiesner RH.

Liver Transpl. 2004 Jan;10(1):36-41.

14.

Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.

Francoz C, Belghiti J, Castaing D, Chazouillères O, Duclos-Vallée JC, Duvoux C, Lerut J, Le Treut YP, Moreau R, Mandot A, Pageaux G, Samuel D, Thabut D, Valla D, Durand F.

Liver Transpl. 2011 Oct;17(10):1137-51. doi: 10.1002/lt.22363. Review.

15.

Impact of the MELD allocation after its implementation in liver transplantation.

Benckert C, Quante M, Thelen A, Bartels M, Laudi S, Berg T, Kaisers U, Jonas S.

Scand J Gastroenterol. 2011 Jul;46(7-8):941-8. doi: 10.3109/00365521.2011.568521. Epub 2011 Mar 28.

PMID:
21443420
16.

Survival benefit after liver transplantation: a single European center experience.

Ravaioli M, Grazi GL, Dazzi A, Bertuzzo V, Ercolani G, Cescon M, Cucchetti A, Masetti M, Ramacciato G, Pinna AD.

Transplantation. 2009 Sep 27;88(6):826-34. doi: 10.1097/TP.0b013e3181b26807.

PMID:
19920783
17.

Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?

Austin MT, Poulose BK, Ray WA, Arbogast PG, Feurer ID, Pinson CW.

Arch Surg. 2007 Nov;142(11):1079-85.

PMID:
18025337
18.

Model for end-stage liver disease-based allocation system for liver transplantation in Argentina: does it work outside the United States?

McCormack L, Gadano A, Lendoire J, Imventarza O, Andriani O, Gil O, Toselli L, Bisigniano L, de Santibañes E.

HPB (Oxford). 2010 Sep;12(7):456-64. doi: 10.1111/j.1477-2574.2010.00199.x.

19.

Higher Mortality in registrants with sudden model for end-stage liver disease increase: Disadvantaged by the current allocation policy.

Massie AB, Luo X, Alejo JL, Poon AK, Cameron AM, Segev DL.

Liver Transpl. 2015 May;21(5):683-9. doi: 10.1002/lt.24102. Epub 2015 Apr 1.

20.

Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.

Gotthardt D, Weiss KH, Baumgärtner M, Zahn A, Stremmel W, Schmidt J, Bruckner T, Sauer P.

BMC Gastroenterol. 2009 Sep 25;9:72. doi: 10.1186/1471-230X-9-72.

Supplemental Content

Support Center